Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
2.500
-0.030 (-1.19%)
At close: Sep 16, 2025, 4:00 PM EDT
2.496
-0.004 (-0.15%)
Pre-market: Sep 17, 2025, 8:00 AM EDT
Catheter Precision Revenue
Catheter Precision had revenue of $212.00K in the quarter ending June 30, 2025, with 127.96% growth. This brings the company's revenue in the last twelve months to $600.00K, up 37.61% year-over-year. In the year 2024, Catheter Precision had annual revenue of $420.00K, down -4.98%.
Revenue (ttm)
$600.00K
Revenue Growth
+37.61%
P/S Ratio
1.99
Revenue / Employee
$27,273
Employees
22
Market Cap
3.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 420.00K | -22.00K | -4.98% |
| Dec 31, 2023 | 442.00K | 428.00K | 3,057.14% |
| Dec 31, 2022 | 14.00K | -8.00K | -36.36% |
| Dec 31, 2021 | 22.00K | -237.00K | -91.51% |
| Dec 31, 2020 | 259.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
VTAK News
- 7 days ago - Catheter Precision Announces Tender Win and First Purchase Order in Croatia - GlobeNewsWire
- 20 days ago - Catheter Precision Announces First Procedures in France as LockeT Expansion Continues - GlobeNewsWire
- 27 days ago - Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study - GlobeNewsWire
- 4 weeks ago - Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split - GlobeNewsWire
- 3 months ago - Catheter Precision, Inc. Comments on Recent Market Activity - GlobeNewsWire
- 4 months ago - Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance - GlobeNewsWire
- 5 months ago - Catheter Precision Makes NYSE American Section 610(b) Public Announcement - GlobeNewsWire
- 6 months ago - Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results - GlobeNewsWire